228 related articles for article (PubMed ID: 19775995)
21. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
22. Role of endothelin-1 in neovascularization of ovarian carcinoma.
Salani D; Di Castro V; Nicotra MR; Rosanò L; Tecce R; Venuti A; Natali PG; Bagnato A
Am J Pathol; 2000 Nov; 157(5):1537-47. PubMed ID: 11073813
[TBL] [Abstract][Full Text] [Related]
23. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
24. Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer.
Coukos G; Conejo-Garcia JR; Buckanovich R; Benencia F
Adv Exp Med Biol; 2007; 590():185-93. PubMed ID: 17191386
[No Abstract] [Full Text] [Related]
25. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
[TBL] [Abstract][Full Text] [Related]
26. Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
[TBL] [Abstract][Full Text] [Related]
27. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours.
Hall GH; Turnbull LW; Bedford K; Richmond I; Helboe L; Atkin SL
Int J Oncol; 2005 Nov; 27(5):1283-8. PubMed ID: 16211223
[TBL] [Abstract][Full Text] [Related]
28. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
Trinh B; Ko SY; Haria D; Barengo N; Naora H
Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
[TBL] [Abstract][Full Text] [Related]
29. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Thaker PH; Han LY; Kamat AA; Arevalo JM; Takahashi R; Lu C; Jennings NB; Armaiz-Pena G; Bankson JA; Ravoori M; Merritt WM; Lin YG; Mangala LS; Kim TJ; Coleman RL; Landen CN; Li Y; Felix E; Sanguino AM; Newman RA; Lloyd M; Gershenson DM; Kundra V; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK
Nat Med; 2006 Aug; 12(8):939-44. PubMed ID: 16862152
[TBL] [Abstract][Full Text] [Related]
30. Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
Schumacher JJ; Dings RP; Cosin J; Subramanian IV; Auersperg N; Ramakrishnan S
Cancer Res; 2007 Apr; 67(8):3683-90. PubMed ID: 17440080
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis in normal and neoplastic ovaries.
Ramakrishnan S; Subramanian IV; Yokoyama Y; Geller M
Angiogenesis; 2005; 8(2):169-82. PubMed ID: 16211363
[TBL] [Abstract][Full Text] [Related]
32. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
33. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
34. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
[TBL] [Abstract][Full Text] [Related]
35. Intratumor microvessel density as a prognostic factor in cancer.
Weidner N
Am J Pathol; 1995 Jul; 147(1):9-19. PubMed ID: 7541613
[No Abstract] [Full Text] [Related]
36. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
Ye W; Ni Z; Yicheng S; Pan H; Huang Y; Xiong Y; Liu T
Int J Oncol; 2019 Dec; 55(6):1296-1312. PubMed ID: 31638182
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of angiogenesis in epithelial ovarian carcinoma.
Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC
Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.
Fu Y; Lai Y; Wang Q; Liu X; He W; Zhang H; Fan C; Yang G
Mol Med Rep; 2013 Jun; 7(6):1726-32. PubMed ID: 23616046
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies.
Zimna A; Kurpisz M
Biomed Res Int; 2015; 2015():549412. PubMed ID: 26146622
[TBL] [Abstract][Full Text] [Related]
40. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
